Nanosonics is a ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe,[2] employing more than 300 people.[3]

Nanosonics Ltd
Company typePublic company
Founded2001 in Australia
Headquarters
Sydney
,
Australia
Areas served
Australia
Key people
Michael Kavanaugh (CEO, President and Managing Director)
Maurie Stang (Chairman)
RevenueIncrease A$100 million (2020)[1] (2020)
Decrease A$10 million (2020)[1]
Total assetsIncrease A$147 million (2020)[1] (2020)
Number of employees
311 [1] (2020)
Websitewww.nanosonics.com

The company’s Trophon is the product used to reduce the spread of Healthcare Acquired Infections (HAIs). Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection.[4]

History

edit

The company was founded in 2001 and headquartered in Sydney, Australia. It listed on the Australian Securities Exchange (ASX) in 2007 with the ticker NAN. In 2009, it launched Trophon, a unique, automated technology for the high-level disinfection of intracavity and surface ultrasound probes.

In 2010 Nanosonics warned that it had become aware of a substandard component being used in the production of its Tryphon EPR ultrasound disinfectant device and had moved to rectify the problem.[5]

In March 2015, Nanosonics was included in the ASX300 Index (Australia’s top 300 companies by market capitalisation).[6]

In 2018 investors were cautioned about Nanosonics relying too much on only one customer, which had its own financial problems, as an outlet for its products.[7]

The COVID-19 pandemic saw Nanosonics share price drop 25 per cent in the first quarter of 2021 due to a ban on elective surgeries and drop off in demand for ultrasound cleaning devices.[8]

References

edit
  1. ^ a b c d "NAN Report 2020" (PDF).
  2. ^ "The Nanosonics Story". www.nanosonics.com.au. Retrieved 31 May 2021.
  3. ^ "Nanosonics Ltd, NAN:ASX profile - FT.com". markets.ft.com. Retrieved 31 May 2021.
  4. ^ "Nanosonics Ltd, NAN:ASX profile - Reuters". Reuters. Retrieved 31 May 2021.
  5. ^ "Nanosonics learns of substandard component". CIO. Retrieved 31 May 2021.
  6. ^ "The Nanosonics Story". www.nanosonics.com.au. Retrieved 31 May 2021.
  7. ^ "Nanosonics and the risks of a company relying on one customer". Money magazine. 9 May 2018. Retrieved 31 May 2021.
  8. ^ "The Nanosonics (ASX:NAN) share price is down 25% this year". The Motley Fool Australia. 24 March 2021. Retrieved 31 May 2021.
edit